MENU
INVA
Stock ticker:
PRICE
CHANGE
CAPITALIZATION
Innoviva (INVA) Ownership - Who owns Innoviva?
Industry: @Pharmaceuticals Other
Profile
Industry
Pharmaceuticals Other
Address
1350 Old Bayshore Highway
Phone
+1 650 238-9600
Employees
112
Web
https://www.inva.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.21B
P/E Ratio
10.91
Total Cash
217M
Projected Growth
N/A
Total Debt
450.72M
Revenue
330.5M
Risk (Beta)
0.52
Dividend Yield
N/A
Total Cash/Share
3.47
Total Debt/Equity
N/A
Revenue/Share
4.45 USD as % of share price
Fundamentals
INVA
Capitalization
1.21B
P/E Ratio
10.91
Risk (Beta)
0.52
Dividend Yield
N/A
Total Cash
217M
Total Cash/Share
3.47
Total Debt
451M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
4.45%
Revenue
330M
ROE
N/A
Book Value
666M
P/B Ratio
1.82
Cash Flow
N/A
Earnings
2.24
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
626K
Current Ratio
12.70
Current Revenue Per Employee
891946.44
Dividends Per Share - Security
0.00
EBITDA
201M
Float
N/A
Float - Current
N/A
Gross Income Margin
91.52
Revenue To Assets
12.41
Shares Held By Institutions
1.67B
Shares Outstanding - Current
62.6M
Total Liabilities
559M
Total Volume MTD
N/A
Value
N/A
Gain YTD
25.997
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a biopharmaceutical company
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
1350 Old Bayshore Highway
Phone
+1 650 238-9600
Employees
112
Web
https://www.inva.com